Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - candesartan cilexetil, quantity: 32 mg; hydrochlorothiazide, quantity: 25 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; iron oxide red; hyprolose; carmellose calcium; iron oxide yellow; macrogol 8000; maize starch - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - hydrochlorothiazide, quantity: 12.5 mg; candesartan cilexetil, quantity: 32 mg - tablet, uncoated - excipient ingredients: carmellose calcium; iron oxide yellow; lactose monohydrate; hyprolose; macrogol 8000; magnesium stearate; maize starch - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - candesartan cilexetil, quantity: 32 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; carmellose calcium; macrogol 8000; magnesium stearate; hyprolose; maize starch; iron oxide red - treatment of hypertension. treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction less than or equal to 40%) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - hydrochlorothiazide, quantity: 12.5 mg; candesartan cilexetil, quantity: 16 mg - tablet, uncoated - excipient ingredients: carmellose calcium; iron oxide yellow; iron oxide red; maize starch; magnesium stearate; hyprolose; lactose monohydrate; macrogol 8000 - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - candesartan cilexetil, quantity: 16 mg - tablet, uncoated - excipient ingredients: macrogol 8000; lactose monohydrate; iron oxide red; magnesium stearate; maize starch; carmellose sodium; hyprolose - treatment of hypertension. treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction less than or equal to 40%) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - candesartan cilexetil, quantity: 8 mg - tablet, uncoated - excipient ingredients: hyprolose; maize starch; macrogol 8000; carmellose calcium; lactose monohydrate; iron oxide red; magnesium stearate - treatment of hypertension. treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction less than or equal to 40%) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - candesartan cilexetil, quantity: 4 mg - tablet, uncoated - excipient ingredients: macrogol 8000; magnesium stearate; hyprolose; carmellose calcium; lactose monohydrate; maize starch - treatment of hypertension. treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction less than or equal to 40%) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - candesartan cilexetil (unii: r85m2x0d68) (candesartan - unii:s8q36md2xx) - candesartan cilexetil 4 mg - atacand is indicated for the treatment of hypertension in adults and children 1 to < 17 years of age. it may be used alone or in combination with other antihypertensive agents. atacand is indicated for the treatment of heart failure (nyha class ii-iv) in adults with left ventricular systolic dysfunction (ejection fraction ≤ 40%) to reduce cardiovascular death and to reduce heart failure hospitalizations [see clinical studies (14.2)] . atacand also has an added effect on these outcomes when used with an ace inhibitor. atacand is contraindicated in patients who are hypersensitive to any component of this product. pregnancy categories c (first trimester) and d (second and third trimesters) [see warnings and precautions (5.1)]. the effect of atacand on labor and delivery in humans is unknown [see warnings and precautions (5.1)]. it is not known whether candesartan is excreted in human milk, but candesartan has been shown to be present in rat milk. because of the potential for adverse effects on the nursing

United States - English - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - candesartan cilexetil (unii: r85m2x0d68) (candesartan - unii:s8q36md2xx) - candesartan cilexetil 4 mg - atacand is indicated for the treatment of hypertension in adults and in children 1 to <17 years of age, to lower blood pressure. lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihy

Ireland - English - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - candesartan cilexetil - tablets - 4 milligram - candesartan